Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

Avacta Therapeutics presents platform-validating data for faridoxorubicin in salivary gland cancer at BIO International Conference

Avacta Therapeutics announced platform-validating clinical data for faridoxorubicin (AVA6000), a tumor-activated oncology drug using its pre

ClinicalKey

Ovarian cancer drug mirvetuximab improves quality of life for patients, UK women report

A new ovarian cancer drug called mirvetuximab is offering women more time and a better quality of life compared to standard chemotherapy. Pa

New drug for cancer patients with ‘limited’ treatment options enters clinical trial

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial